Age, Risk, and the "Looks-Maxing" Warning Huberman's most cautionary comments concerned young people using peptides without understanding the risks: "The whole looks-maxing phenomenon is really, really dangerous and foolish, especially in people younger than 40
The GLP-Squared is $289/mo month-to-month, or from $249/mo on the 3-month plan
The research industry is flooded with under-dosed vials and fake lab reports
In highly specialised settings, a clinician might theoretically consider combining a GH-axis modulator with an incretin-based therapy for a patient with a specific, well-characterised metabolic phenotype for instance, significant visceral adiposity in the context of HIV-associated lipodystrophy who has not responded adequately to standard treatments
A recent meta-analysis comprising nearly 300,000 individuals showed that patients with NAFLD have an increased risk of developing T2D compared to controls [hazard ratio (HR) 2.22, 95% CI 1.842.60], and that risk of T2D increases across the stages of NAFLD (9)
Appetite, 57 (1), 237246